KE
Keytruda
Pembrolizumab, sold under the brand name Keytruda, is a humanized monoclonal antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy to treat many types of cancer. It is administered by slow intravenous injection.
Last 30 days2Stories3Articles1Events
30-day activity pulse
Last 7d articles
2
Prior 7d baseline
0
Trend
new
Peak day
1
Peak article volume on 2026-04-16.
Last 24 hoursStories, events, map, and sources are limited to the past 24 hours. Use the Wikipedia link or the API for deeper history.